These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 24153434)

  • 1. Comment on "tissue factor expressed by microparticles is associated with mortality but not with thrombosis in cancer patients".
    Geddings JE; Mackman N
    Thromb Haemost; 2014 Jan; 111(1):180-1. PubMed ID: 24153434
    [No Abstract]   [Full Text] [Related]  

  • 2. "tissue factor expressed by microparticles is associated with mortality but not with thrombosis in cancer patients." reply to a comment by Geddings and Mackman.
    Hernández C; Roncal C; Orbe J; Páramo JA
    Thromb Haemost; 2014 Jan; 111(1):182. PubMed ID: 24154596
    [No Abstract]   [Full Text] [Related]  

  • 3. Tissue factor expressed by microparticles is associated with mortality but not with thrombosis in cancer patients.
    Hernández C; Orbe J; Roncal C; Alvarez-Hernandez M; Martinez de Lizarrondo S; Alves MT; García Mata J; Páramo JA
    Thromb Haemost; 2013 Sep; 110(3):598-608. PubMed ID: 23803792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients.
    Geddings JE; Mackman N
    Blood; 2013 Sep; 122(11):1873-80. PubMed ID: 23798713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue factor-bearing microparticles and inflammation: a potential mechanism for the development of venous thromboembolism in cancer.
    Date K; Ettelaie C; Maraveyas A
    J Thromb Haemost; 2017 Dec; 15(12):2289-2299. PubMed ID: 29028284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy.
    Zwicker JI; Liebman HA; Neuberg D; Lacroix R; Bauer KA; Furie BC; Furie B
    Clin Cancer Res; 2009 Nov; 15(22):6830-40. PubMed ID: 19861441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of tissue factor bearing microparticles in cancer associated thrombosis.
    Zwicker JI
    Thromb Res; 2010 Apr; 125 Suppl 2():S89-91. PubMed ID: 20434015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue factor expressed by circulating cancer cell-derived microparticles drastically increases the incidence of deep vein thrombosis in mice: comment.
    Patil R; Ghosh K; Shetty S
    J Thromb Haemost; 2015 Sep; 13(9):1737-8. PubMed ID: 26179190
    [No Abstract]   [Full Text] [Related]  

  • 9. Microparticle bearing tissue factor: a link between promyelocytic cells and hypercoagulable state.
    Gheldof D; Mullier F; Bailly N; Devalet B; Dogné JM; Chatelain B; Chatelain C
    Thromb Res; 2014 Mar; 133(3):433-9. PubMed ID: 24290525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue factor in tumor microenvironment: a systematic review.
    Han X; Guo B; Li Y; Zhu B
    J Hematol Oncol; 2014 Aug; 7():54. PubMed ID: 25084809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microparticles in vascular disorders: how tissue factor-exposing vesicles contribute to pathology and physiology.
    Kleinjan A; Böing AN; Sturk A; Nieuwland R
    Thromb Res; 2012 Oct; 130 Suppl 1():S71-3. PubMed ID: 23026670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microparticles and cancer thrombosis in animal models.
    Mege D; Mezouar S; Dignat-George F; Panicot-Dubois L; Dubois C
    Thromb Res; 2016 Apr; 140 Suppl 1():S21-6. PubMed ID: 27067974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Tissue Factor in Tumor Progression and Cancer-Associated Thrombosis.
    Rondon AMR; Kroone C; Kapteijn MY; Versteeg HH; Buijs JT
    Semin Thromb Hemost; 2019 Jun; 45(4):396-412. PubMed ID: 31096312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High concentration of the plasma microparticles for venous thromboembolism associated with lung cancer.
    Wang M; Huang X; Zhu M; Zhang S; Zhang Y
    Clin Respir J; 2020 May; 14(5):481-487. PubMed ID: 32031323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of platelet activation prevents the P-selectin and integrin-dependent accumulation of cancer cell microparticles and reduces tumor growth and metastasis in vivo.
    Mezouar S; Darbousset R; Dignat-George F; Panicot-Dubois L; Dubois C
    Int J Cancer; 2015 Jan; 136(2):462-75. PubMed ID: 24889539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Predictive value of tissue factor-associated platelet microparticles in thrombosis of patients with lymphoma].
    Tang YL; Zhou Y; Wang CB; Qin Y; Feng J; Qin J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Apr; 20(2):325-8. PubMed ID: 22541091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human pancreatic tumors grown in mice release tissue factor-positive microvesicles that increase venous clot size.
    Hisada Y; Ay C; Auriemma AC; Cooley BC; Mackman N
    J Thromb Haemost; 2017 Nov; 15(11):2208-2217. PubMed ID: 28834179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombin generation and microparticles in inflammatory bowel diseases.
    Stadnicki A
    J Pediatr Gastroenterol Nutr; 2013 Apr; 56(4):343. PubMed ID: 23531480
    [No Abstract]   [Full Text] [Related]  

  • 19. Microvesicles as risk markers for venous thrombosis.
    Rautou PE; Mackman N
    Expert Rev Hematol; 2013 Feb; 6(1):91-101. PubMed ID: 23373784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelial, platelet, and tissue factor-bearing microparticles in cancer patients with and without venous thromboembolism.
    Campello E; Spiezia L; Radu CM; Bulato C; Castelli M; Gavasso S; Simioni P
    Thromb Res; 2011 May; 127(5):473-7. PubMed ID: 21256535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.